FDA Approves Ocrelizumab for Pediatric Relapsing MS

The FDA approval makes ocrelizumab a new treatment option for children aged 10 years and older with relapsing-remitting multiple sclerosis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-approves-ocrelizumab-pediatric-relapsing-ms-2026a1000f5m?src=rss

Author :

Publish date : 2026-05-11 19:07:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

FDA Approves Ocrelizumab for Pediatric Relapsing MS

Hantavirus Webinar May 12: What You Need to Know

Food-as-Medicine Intervention Signals BP Benefit in High-Risk Adults

Related Posts

Millions Drop Obamacare Coverage After Subsidies Expire and Costs Rise

‘Wait a Minute. Isn’t This the Same Drug?’: What We Heard This Week

Oral FGFR1-3 Inhibitor Boosted Height Velocity in Common Genetic Growth Disorder

Catherine completes Three Peaks Challenge to ‘explore life beyond’ cancer diagnosis

Hospitals Are Using AI to Detect Intimate Partner Violence. That’s a Problem.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Millions Drop Obamacare Coverage After Subsidies Expire and Costs Rise

‘Wait a Minute. Isn’t This the Same Drug?’: What We Heard This Week

Oral FGFR1-3 Inhibitor Boosted Height Velocity in Common Genetic Growth Disorder

Catherine completes Three Peaks Challenge to ‘explore life beyond’ cancer diagnosis

Hospitals Are Using AI to Detect Intimate Partner Violence. That’s a Problem.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Recommending Blood Tests for CRC Without Guardrails Risks Confusion

Access Denied

Categories

Archives